Boston Scientific Fights For Higher HTA Payment, But Is Undercut By AMS
This article was originally published in The Gray Sheet
Executive Summary
American Medical Systems' argument that its HerOption cryosurgical device requires ultrasonic guidance and therefore justifies higher payment than Boston Scientific's Hydro ThermAblator proved persuasive to CMS' APC Advisory Panel